🔴 Noveris Health Sciences is trading 5.71% down today amid proposed convertible-debenture dilution overhang

Noveris Health Sciences is trading 5.71% down at CA$0.17 as biotech-sector weakness pressured higher-risk growth stocks during August 28, 2026 trading.

• No confirmed new announcement was identified for August 28.
• A proposed private placement of up to CA$500,000 in convertible debentures is expected to close around August 28, creating a potential dilution overhang for investors.